Idexx Laboratories (IDXX) Net Cash Flow (2009 - 2026)

Idexx Laboratories (IDXX) has reported Net Cash Flow for 18 consecutive years, with $21.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Cash Flow rose 117.44% year-over-year to $21.3 million; the TTM figure through Mar 2026 stood at $23.8 million (up 110.57% YoY), while the FY2025 annual figure was -$119.4 million, up 23.53% from the prior year.
• Net Cash Flow came in at $21.3 million for Q1 2026 at Idexx Laboratories, up from -$28.1 million in the prior quarter.
• The five-year high for Net Cash Flow was $201.6 million in Q3 2023, with the low at -$122.0 million in Q1 2025.
• Average Net Cash Flow over 5 years is $3.6 million, with a median of -$1.7 million recorded in 2023.
• Across the five-year window, Net Cash Flow jumped 7091.35% in 2022 and sank 3021.01% in 2024, its largest moves.
• Year by year, Net Cash Flow stood at $7.5 million in 2022, then jumped by 1472.03% to $117.6 million in 2023, then sank by 109.02% to -$10.6 million in 2024, then plunged by 164.83% to -$28.1 million in 2025, then jumped by 175.78% to $21.3 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $21.3 million, -$28.1 million, and $44.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.